PMLive4 天
FDA approves Soleno’s Vykat XR as first treatment for hyperphagia in Prader-Willi syndrome
The US Food and Drug Administration (FDA) has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release ...
How Trump's cuts could snag a small Peninsula drug company and kids with a rare overeating ...
Soleno Therapeutics awaits FDA decision on its drug for Prader-Willi Syndrome, facing challenges amid Trump Administration's government changes.
来自MSN1 个月
CRISPR Unlocks ‘Sleeping’ Genes—A Potential Cure for Prader-Willi Syndrome?
A single genetic switch could potentially treat a rare but severe childhood disorder. Prader-Willi Syndrome (PWS) affects approximately 1 in 15,000 newborns, causing insatiable hunger, obesity ...